Suzanne Jansen

Suzanne Jansen is a Molecular Diagnostic Specialist at MDxHealth, where since February 2020, the focus has been on providing non-invasive molecular diagnostics to enhance prostate cancer patient stratification and early detection. Prior to this role, Suzanne Jansen had an extensive career at GlaxoSmithKline Pharmaceuticals, serving as a Senior Executive Pharmaceutical Sales Specialist and Senior Healthcare Consultant from August 1996 to January 2019, contributing to consumer healthcare initiatives. Suzanne Jansen holds a Bachelor of Arts in Psychology from California State University, Fullerton.